Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-14

Clinical Trial Update: The Efficacy of Stabilized Chlorine Dioxide Rinse as a Chemical Adjuvant for Treatment of Per-implant Mucositis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating stabilized chlorine dioxide rinse as a chemical adjuvant for treating peri-implant mucositis has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stabilized chlorine dioxide rinse

Snippet

Sponsor: Rowpar Pharmaceuticals, Inc. | Conditions: Peri-implant Mucositis | Phase 4 | Status: COMPLETED | Results posted: 2022-04-14